Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Related Citations for PubMed (Select 17998097)

1.

Gallium-68-labeled DOTA-rhenium-cyclized alpha-melanocyte-stimulating hormone analog for imaging of malignant melanoma.

Wei L, Miao Y, Gallazzi F, Quinn TP, Welch MJ, Vāvere AL, Lewis JS.

Nucl Med Biol. 2007 Nov;34(8):945-53. Epub 2007 Sep 4.

2.

Imaging of melanoma using 64Cu- and 86Y-DOTA-ReCCMSH(Arg11), a cyclized peptide analogue of alpha-MSH.

McQuade P, Miao Y, Yoo J, Quinn TP, Welch MJ, Lewis JS.

J Med Chem. 2005 Apr 21;48(8):2985-92.

PMID:
15828837
3.

Synthesis and biologic evaluation of 64Cu-labeled rhenium-cyclized alpha-MSH peptide analog using a cross-bridged cyclam chelator.

Wei L, Butcher C, Miao Y, Gallazzi F, Quinn TP, Welch MJ, Lewis JS.

J Nucl Med. 2007 Jan;48(1):64-72.

4.

A gallium-labeled DOTA-alpha-melanocyte- stimulating hormone analog for PET imaging of melanoma metastases.

Froidevaux S, Calame-Christe M, Schuhmacher J, Tanner H, Saffrich R, Henze M, Eberle AN.

J Nucl Med. 2004 Jan;45(1):116-23.

5.

64Cu-labeled alpha-melanocyte-stimulating hormone analog for microPET imaging of melanocortin 1 receptor expression.

Cheng Z, Xiong Z, Subbarayan M, Chen X, Gambhir SS.

Bioconjug Chem. 2007 May-Jun;18(3):765-72. Epub 2007 Mar 10.

6.

Evaluation of an (111)In-DOTA-rhenium cyclized alpha-MSH analog: a novel cyclic-peptide analog with improved tumor-targeting properties.

Chen J, Cheng Z, Owen NK, Hoffman TJ, Miao Y, Jurisson SS, Quinn TP.

J Nucl Med. 2001 Dec;42(12):1847-55.

7.

Modification of the structure of a metallopeptide: synthesis and biological evaluation of (111)In-labeled DOTA-conjugated rhenium-cyclized alpha-MSH analogues.

Cheng Z, Chen J, Miao Y, Owen NK, Quinn TP, Jurisson SS.

J Med Chem. 2002 Jul 4;45(14):3048-56. Erratum in: J Med Chem 2002 Sep 26;45(20):4588.

PMID:
12086490
8.
9.

Development of high-specific-activity (68)Ga-labeled DOTA-rhenium-cyclized alpha-MSH peptide analog to target MC1 receptors overexpressed by melanoma tumors.

Cantorias MV, Figueroa SD, Quinn TP, Lever JR, Hoffman TJ, Watkinson LD, Carmack TL, Cutler CS.

Nucl Med Biol. 2009 Jul;36(5):505-13. doi: 10.1016/j.nucmedbio.2009.01.017. Epub 2009 May 7.

PMID:
19520291
10.

Radiofluorinated rhenium cyclized α-MSH analogues for PET imaging of melanocortin receptor 1.

Ren G, Liu S, Liu H, Miao Z, Cheng Z.

Bioconjug Chem. 2010 Dec 15;21(12):2355-60. doi: 10.1021/bc100391a. Epub 2010 Nov 12.

11.

111In-DOTA-Re(Cys3,4,10,d-Phe7,Arg11)αMSH3-13.

Cheng KT, Cheng Z, Quinn TP.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2007 Sep 01 [updated 2007 Dec 17].

13.

Gallium-67-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide for primary and metastatic melanoma imaging.

Guo H, Yang J, Shenoy N, Miao Y.

Bioconjug Chem. 2009 Dec;20(12):2356-63. doi: 10.1021/bc900428x.

14.

203Pb-labeled alpha-melanocyte-stimulating hormone peptide as an imaging probe for melanoma detection.

Miao Y, Figueroa SD, Fisher DR, Moore HA, Testa RF, Hoffman TJ, Quinn TP.

J Nucl Med. 2008 May;49(5):823-9. doi: 10.2967/jnumed.107.048553. Epub 2008 Apr 15.

15.

Metastatic melanoma imaging with an (111)In-labeled lactam bridge-cyclized alpha-melanocyte-stimulating hormone peptide.

Guo H, Shenoy N, Gershman BM, Yang J, Sklar LA, Miao Y.

Nucl Med Biol. 2009 Apr;36(3):267-76. doi: 10.1016/j.nucmedbio.2009.01.003.

16.

Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog.

Cheng Z, Zhang L, Graves E, Xiong Z, Dandekar M, Chen X, Gambhir SS.

J Nucl Med. 2007 Jun;48(6):987-94. Epub 2007 May 15.

17.

PET of malignant melanoma using 18F-labeled metallopeptides.

Ren G, Liu Z, Miao Z, Liu H, Subbarayan M, Chin FT, Zhang L, Gambhir SS, Cheng Z.

J Nucl Med. 2009 Nov;50(11):1865-72. doi: 10.2967/jnumed.109.062877. Epub 2009 Oct 16.

18.

Effects of the amino acid linkers on the melanoma-targeting and pharmacokinetic properties of 111In-labeled lactam bridge-cyclized alpha-MSH peptides.

Guo H, Yang J, Gallazzi F, Miao Y.

J Nucl Med. 2011 Apr;52(4):608-16. doi: 10.2967/jnumed.110.086009. Epub 2011 Mar 18.

19.

86Y-DOTA-rhenium-cyclized-[Cys3,4,10,D-Phe7,Arg11]α-MSH3-13.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2009 May 30 [updated 2009 Jul 14].

20.

Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues.

Chen J, Cheng Z, Hoffman TJ, Jurisson SS, Quinn TP.

Cancer Res. 2000 Oct 15;60(20):5649-58.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk